Literature DB >> 20869357

Clinical implications of the change of cardiac troponin I levels in patients with acute chest pain - an evaluation with respect to the Universal Definition of Myocardial Infarction.

Kai M Eggers1, Allan S Jaffe, Per Venge, Bertil Lindahl.   

Abstract

BACKGROUND: The Universal Definition of Myocardial Infarction incorporates elevated cardiac troponin levels (> 99th percentile) together with a significant rise/fall of troponins as biochemical criterion. We sought to evaluate the clinical implications of the relative change of cardiac troponin I (cTnI) levels with respect to the Universal Definition in patients with acute chest pain.
METHODS: cTnI (Stratus CS) was measured serially in 454 patients within 24h from admission. Acute myocardial infarction (AMI) was defined using the criteria adapted to the ESC/ACC consensus document, or corresponding to the Universal Definition together with prespecified cTnI changes of ≥ 20%, ≥ 50% and ≥ 100%. Follow-up was completed after 5.8 years.
RESULTS: A peak cTnI level above the 99th percentile together with a cTnI change of ≥ 20% was found in 160 patients of whom 25 did not have AMI according to the ESC/ACC criteria. These 160 patients had a significantly raised mortality (HR 2.5 [95% CI 1.7-3.8]). Higher cTnI deltas were not associated with higher mortalities but identified smaller patient cohorts at risk.
CONCLUSIONS: The Universal Definition of AMI together with a ≥ 20% cTnI change appears to improve the discrimination of acute from chronic causes of cTnI release, and allows a reliable identification of patients at risk.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20869357     DOI: 10.1016/j.cca.2010.09.020

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

1.  Diagnostic performance of rising, falling, or rising and falling kinetic changes of high-sensitivity cardiac troponin T in an unselected emergency department population.

Authors:  Moritz Biener; Matthias Mueller; Mehrshad Vafaie; Allan S Jaffe; Christian Widera; Hugo A Katus; Evangelos Giannitsis
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-07-15

Review 2.  High-Sensitivity Cardiac Troponin for the Diagnosis of Patients with Acute Coronary Syndromes.

Authors:  Vlad C Vasile; Allan S Jaffe
Journal:  Curr Cardiol Rep       Date:  2017-08-24       Impact factor: 2.931

3.  [Essential cardiac biomarkers in myocardial infarction and heart failure].

Authors:  M Mueller; E Giannitsis; H A Katus
Journal:  Herz       Date:  2014-09       Impact factor: 1.443

Review 4.  Cardiac troponin level elevations not related to acute coronary syndromes.

Authors:  Evangelos Giannitsis; Hugo A Katus
Journal:  Nat Rev Cardiol       Date:  2013-08-27       Impact factor: 32.419

5.  A smartphone-assisted pressure-measuring-based diagnosis system for acute myocardial infarction diagnosis.

Authors:  Guolin Hong; Gang Rui; Dongdong Zhang; Mingjian Lian; Yuanyuan Yang; Ping Chen; Huijing Yang; Zhichao Guan; Wei Chen; Yan Wang
Journal:  Int J Nanomedicine       Date:  2019-04-08

6.  Measurement of cardiac troponins to detect myocardial infarction using high-sensitivity assays: South African guidelines.

Authors:  R Delport; J A Ker
Journal:  Cardiovasc J Afr       Date:  2012-11       Impact factor: 1.167

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.